SAN DIEGO, May 30, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX ), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced that Stephen Farr, Ph.D., President, and Ann Rhoads, Chief Financial Officer, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City on June 4, 2014.

Event : Jefferies 2014 Global Healthcare Conference

Date : Wednesday, June 4, 2014

Place : New York City

Time : 2:30 pm ET/ 11:30 am PT

The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Dr. Farr and Ms. Rhoads will provide a business update and will also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. (Nasdaq: ZGNX ) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

FPR

Investors Zack Kubow, The Ruth Group 646.536.7020, Media Aaron Estrada, The Ruth Group 646.536.7028,